IL2 and Huntington disease: Another study showed that KT patients had significantly decreased frequencies of spike-specific IFN-γ+TNF-α+IL-2+ polyfunctional T cells compared to HD and healthy controls, and all of them had received two doses of BNT162b2 [17].